FCPVX
Price
$23.84
Change
+$0.47 (+2.01%)
Updated
Jun 2 closing price
Net Assets
5.13B
VISVX
Price
$56.60
Change
+$0.48 (+0.86%)
Updated
Jun 2 closing price
Net Assets
64.9B
Interact to see
Advertisement

FCPVX vs VISVX

Header iconFCPVX vs VISVX Comparison
Open Charts FCPVX vs VISVXBanner chart's image
FCPVX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
FCPVX vs. VISVX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCPVX is a Hold and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 64.9B vs. FCPVX (5.13B). VISVX pays higher dividends than FCPVX: VISVX (1.65) vs FCPVX (0.89). FCPVX was incepted earlier than VISVX: FCPVX (22 years) vs VISVX (28 years). FCPVX (0.91) is less costly to investors than VISVX (0.19). FCPVX is a more actively managed with annual turnover of: 96.00 vs. VISVX (25.00). FCPVX (0) and VISVX (0) have matching initial minimum investment requirements. VISVX (24.89) and FCPVX (23.71) have marching annual gain over last year. VISVX return over 5 years is better than : 34.36 vs. FCPVX (7.31).
FCPVXVISVXFCPVX / VISVX
Total Expense Ratio0.910.19479%
Annual Report Gross Expense Ratio0.910.19479%
Fund Existence22 years28 years-
Gain YTD16.85010.611159%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.13B64.9B8%
Annual Yield % from dividends0.891.6554%
Returns for 1 year23.7124.8995%
Returns for 3 years31.0149.8062%
Returns for 5 years7.3134.3621%
Returns for 10 years36.53130.3028%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APEI52.280.97
+1.89%
American Public Education
FERG227.603.22
+1.44%
Ferguson Enterprises Inc.
SCNX0.39-0.01
-1.94%
Scienture Holdings Inc
ACIW43.69-1.34
-2.98%
ACI Worldwide
TNXP11.71-0.58
-4.72%
Tonix Pharmaceuticals Holding Corp